Sanofi Translate Bio mRNA COVID-19 vaccine collaboration 2020
Loading viewer...
investor_presentation
Format: PDF investor_presentation
Sanofi announced an expanded collaboration with Translate Bio to develop an mRNA-based COVID-19 vaccine. The presentation outlines Sanofi's COVID-19 response strategy and discusses mRNA technology applications. Key speakers include executives from both Sanofi Pasteur and Translate Bio.
